XIMAD INC. – Trademark Portfolio
Entity Type: 03
XIMAD INC. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 11 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include ZIMAD, DIG OUT!, MAGIC WORD, MAGIC SOLITAIRE, and MAGIC CROSS STITCH. The owner is based in Hollywood, FL.
2252 Hayes St.
Hollywood, FL 33020
Showing of trademarks Trademarks
Trademark Classifications
XIMAD INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does XIMAD INC. have?
XIMAD INC. has 11 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned, 2 cancelled.
What trademark classes does XIMAD INC. file in?
XIMAD INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are XIMAD INC.'s most well-known trademarks?
XIMAD INC.'s registered trademark portfolio includes well-known marks such as ZIMAD, DIG OUT!, MAGIC WORD, MAGIC SOLITAIRE, and MAGIC CROSS STITCH. These are among 7 currently registered trademarks in the portfolio.
What is XIMAD INC.'s trademark registration success rate?
XIMAD INC. has a 64% trademark registration rate, with 7 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.